Stockscreener 앱 받기
6.45
2.71%
-0.18
시간 외 거래:
6.50
0.05
+0.78%
전일 마감가:
$6.63
열려 있는:
$6.54
하루 거래량:
40,818
Relative Volume:
0.02
시가총액:
$4.59M
수익:
$574.20K
순이익/손실:
$-7.15M
주가수익비율:
-0.4062
EPS:
-15.8778
순현금흐름:
$-7.00M
1주 성능:
+2.71%
1개월 성능:
+254.40%
6개월 성능:
+204.25%
1년 성능:
+706.96%
1일 변동 폭
$6.3849
$6.69
1주일 범위
$5.95
$6.69
52주 변동 폭
$0.5079
$9.50
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
6.45 | 4.47M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
Aethlon Medical shareholders approve equity plan amendments and board elections - Investing.com Canada
Form 8K Aethlon Medical Inc For: 1 October - Investing.com India
AEMD: All proposals except preferred stock authorization were approved, with no stockholder questions - TradingView
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
North Immunology, Aethlon Merge to Advance NOR-101 for AD - Dermatology Times
Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders? - Times Argus
What Does Aethlon Medical (NASDAQ:AEMD) Reveal About Penny Stocks? - kalkinemedia.com
Law firm investigates fairness of Aethlon Medical's merger deal for shareholders. - Pluang
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) - PR Newswire
Aethlon Stock Pulls Back: What's Going On? - Benzinga
Aethlon Medical shares fall 9% after surging 300% on North Immunology merger news - scanx.trade
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral - Investing.com
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral By Investing.com - Investing.com South Africa
Aethlon Medical Q1FY27 Results: Operating expenses fall 11.9% to $1.6 million - scanx.trade
Aethlon Medical Q1 2027 Earnings Call Transcript - Benzinga
US Stocks Today: Top Gainers and Losers on Sept 18 - HDFC Sky
AEMD, OKLO, DAIC, XENE, MRNA: 5 Trending Stocks TodayModerna (NASDAQ:MRNA) - Benzinga
Aethlon Medical Shares Surge Over 470% on Reverse Merger That Hands Control to North Immunology - finance.biggo.com
Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology - Procopio
Aethlon Medical To Merge With North Immunology And Raise $180 Million To Advance Atopic Dermatitis Drug NOR-101 - Pulse 2.0
North Immunology to go public via Aethlon reverse merger backed by USD 180m PIPE - AllSci
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
North Immunology joins biotech reverse merger boom with Aethlon deal - BioPharma Dive
Medical Tech Stock Aethlon Medical, Inc. (Nasdaq: AEMD) Soars on Merger News - Investorideas.com
AEMD Stock Soars 460% on the North Immunology Merger — But What Do Shareholders Actually Own? - TOP1markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE – RGR), Atkore, Inc. (NYSE – ATKR), Centerspace (NYSE – CSR), Aethlon Medical, Inc. (Nasdaq – AEMD) - Carroll County Mirror-Democrat
Aethlon Medical Jumps on North Immunology Merger and $180 Million Financing Plan - Quiver Quantitative
Aethlon Medical (AEMD) Stock Rockets 471% Following North Immunology Merger Announcement - Blockonomi
Remember to sell bro 😘 - Moomoo
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology - Pharmaceutical Executive
Aethlon’s 467% Stock Rally Reflects a $16.5 Million Merger Stub, Not a $346.5 Million Windfall - TechStock²
Trending Stocks Today | Aethlon Medical Soars 475.17% - moomoo.com
Aethlon Medical, North Immunology Plan Merger Backed by $180 Million Financing - citybiz
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Yahoo Finance
Why Did Aethlon Medical Stock Jump 4X on Thursday?Aethlon Medical (NASDAQ:AEMD) - Benzinga
Aethlon Medical to Merge With North Immunology in All-Stock Deal Backed by $180 Million Financing - Minichart
AEMD Surges 346% Premarket on Merger News; Price-to-Sales Signals Market Skepticism - GuruFocus
North Immunology deal makes Aethlon (NASDAQ: AEMD) a minority owner - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$180 million fuels Aethlon Medical (NASDAQ: AEMD) merger built around a new skin-disease antibody - Stock Titan
AEMD Stock Whipsaws As Traders Eye Conference Catalyst - timothysykes.com
Aethlon Medical stock soars over 400% on North Immunology merger deal - Investing.com
Aethlon Medical stock soars over 400% on North Immunology merger deal By Investing.com - Investing.com South Africa
Aethlon Medical (AEMD) Announces Merger with North Immunology, M - GuruFocus
The AI's pre-market trailing stop-loss is truly impressive - Moomoo
$Aethlon Medical (AEMD.US)$ i got fomo selling early so gotta give it another shot.. 😘😘 @Michael_11 - Moomoo
Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing - TradingView
Halper Sadeh probes Aethlon Medical merger for shareholder fairness - scanx.trade
Aethlon Medical (NASDAQ: AEMD) Revises Executive Severance Agreements to Enable One-Time Lump Sum Payments - kalkinemedia.com
Aethlon Medical amends executive agreements to change severance payment terms - Investing.com Australia
Form 8K Aethlon Medical Inc For: 15 September By Investing.com - Investing.com Nigeria
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
0.38%
자본화:
|
볼륨(24시간):